E
T2 Biosystems, Inc.
TTOO
$0.1315
-$0.0005-0.38%
E
Sell
3/14/2023Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 03/14/2023.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/27/2023Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index.
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 02/09/2023.
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index.
D
Sell
1/26/2023Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 1/26/2023 due to an increase in the volatility index and total return index.
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 1/26/2023 due to an increase in the volatility index and total return index.
D
Sell
11/21/2022Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 11/21/2022 due to a decline in the solvency index and volatility index.
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 11/21/2022 due to a decline in the solvency index and volatility index.
D
Sell
8/10/2022Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 8/10/2022 due to an increase in the volatility index.
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 8/10/2022 due to an increase in the volatility index.
D
Sell
7/26/2022Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 7/26/2022 due to a decline in the total return index and volatility index.
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 7/26/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 05/16/2022.
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 05/04/2022.
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 04/21/2022.
T2 Biosystems, Inc. (TTOO) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index and volatility index.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
11/23/2021Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 11/23/2021.
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
5/1/2020Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 5/1/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Total revenue increased 83.01% from $1.68M to $3.07M, operating cash flow increased 25.24% from -$13.54M to -$10.12M, and earnings per share increased from -$0.312 to -$0.2932.
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 5/1/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Total revenue increased 83.01% from $1.68M to $3.07M, operating cash flow increased 25.24% from -$13.54M to -$10.12M, and earnings per share increased from -$0.312 to -$0.2932.
D
Sell
10/18/2017Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E+ on 10/18/2017 due to an increase in the total return index and volatility index.
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E+ on 10/18/2017 due to an increase in the total return index and volatility index.
E
Sell
8/9/2017Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 8/9/2017 due to a noticeable decline in the solvency index, growth index and valuation index. Debt to equity increased from 1.58 to 3.35, the quick ratio declined from 6.65 to 4.5, and EBIT declined 5.77% from -$13.15M to -$13.9M.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 8/9/2017 due to a noticeable decline in the solvency index, growth index and valuation index. Debt to equity increased from 1.58 to 3.35, the quick ratio declined from 6.65 to 4.5, and EBIT declined 5.77% from -$13.15M to -$13.9M.
D
Sell
11/11/2016Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E+ on 11/11/2016 due to a substantial increase in the growth index, solvency index and valuation index. Debt to equity declined from 1.54 to 0.65, the quick ratio increased from 2.89 to 4.07, and operating cash flow increased 12.32% from -$12.95M to -$11.36M.
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E+ on 11/11/2016 due to a substantial increase in the growth index, solvency index and valuation index. Debt to equity declined from 1.54 to 0.65, the quick ratio increased from 2.89 to 4.07, and operating cash flow increased 12.32% from -$12.95M to -$11.36M.
E
Sell
8/10/2016Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 8/10/2016 due to a large decline in the growth index, solvency index and valuation index. Debt to equity increased from 0.87 to 1.54, the quick ratio declined from 4.07 to 2.89, and total revenue declined 9.67% from $1.1M to $990.
T2 Biosystems, Inc. (TTOO) was downgraded to E+ from D- on 8/10/2016 due to a large decline in the growth index, solvency index and valuation index. Debt to equity increased from 0.87 to 1.54, the quick ratio declined from 4.07 to 2.89, and total revenue declined 9.67% from $1.1M to $990.
D
Sell
3/11/2016Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index.
T2 Biosystems, Inc. (TTOO) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index.
D
Sell
11/2/2015Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 11/2/2015 due to an increase in the volatility index.
T2 Biosystems, Inc. (TTOO) was upgraded to D from D- on 11/2/2015 due to an increase in the volatility index.
D
Sell
5/1/2015Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E on 5/1/2015 due to an increase in the total return index and valuation index.
T2 Biosystems, Inc. (TTOO) was upgraded to D- from E on 5/1/2015 due to an increase in the total return index and valuation index.
E
Sell
4/27/2015Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E from E+ on 4/27/2015 due to a major decline in the volatility index and total return index.
T2 Biosystems, Inc. (TTOO) was downgraded to E from E+ on 4/27/2015 due to a major decline in the volatility index and total return index.
E
Sell
2/2/2015Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to E+ from E on 2/2/2015 due to a large increase in the volatility index and total return index.
T2 Biosystems, Inc. (TTOO) was upgraded to E+ from E on 2/2/2015 due to a large increase in the volatility index and total return index.
E
Sell
1/5/2015Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to E from E- on 1/5/2015 due to an increase in the volatility index.
T2 Biosystems, Inc. (TTOO) was upgraded to E from E- on 1/5/2015 due to an increase in the volatility index.
E
Sell
12/18/2014Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E- from E on 12/18/2014 due to a decline in the volatility index and total return index.
T2 Biosystems, Inc. (TTOO) was downgraded to E- from E on 12/18/2014 due to a decline in the volatility index and total return index.
E
Sell
12/3/2014Upgraded
T2 Biosystems, Inc. (TTOO) was upgraded to E from E- on 12/3/2014 due to an increase in the volatility index.
T2 Biosystems, Inc. (TTOO) was upgraded to E from E- on 12/3/2014 due to an increase in the volatility index.
E
Sell
11/7/2014Downgrade
T2 Biosystems, Inc. (TTOO) was downgraded to E- from E on 11/7/2014 due to a decline in the valuation index.
T2 Biosystems, Inc. (TTOO) was downgraded to E- from E on 11/7/2014 due to a decline in the valuation index.
E
Sell
10/30/2014None
T2 Biosystems, Inc. (TTOO) was downgraded to E from U on 10/30/2014.
T2 Biosystems, Inc. (TTOO) was downgraded to E from U on 10/30/2014.
OTC PK
03/12/2025 3:49PM Eastern
Quotes delayed
